Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Angiotensin II Antibodies:
anti-Rat (Rattus) Angiotensin II Antibodies:
anti-Mouse (Murine) Angiotensin II Antibodies:
Go to our pre-filtered search.
Human Polyclonal Angiotensin II Primary Antibody for IF (p), IHC (p) - ABIN670521
Anand, Yiangou, Sinisi, Fox, MacQuillan, Quick, Korchev, Bountra, McCarthy, Anand: Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies. in Molecular pain 2015
Show all 2 references for ABIN670521
NOXs had two time-dependent reactions in response to Ang II (show AGT Antibodies) stimulation via MAPK (show MAPK1 Antibodies) pathwa
increased Ang-II/Ang-(1 (show ANGPT1 Antibodies)-7) ratios may lead to Ang-II (show AGT Antibodies) over-activation and aggravate atherosclerosis progression.
urinary angiotensinogen (show AGT Antibodies) could be a prognostic marker of the albuminuria reduction effects of olmesartan in patients with metabolic syndrome
AGT (show AGXT Antibodies) expression is significantly upregulated in human masticatory mucosa during wound healing
Urinary angiotensinogen reflects intrarenal RAS status, and is of value to assess the severity of acute tubular necrosis .
Data suggest that enhanced survival of normal prostate epithelial cells (PNT1A cell line) in presence of either or both angiotensin II (Ang II) and relaxin 2 (RLN2 (show RLN1 Antibodies)) appears to be associated with increased ratio of BCL2 (show BCL2 Antibodies)/BAX (show BAX Antibodies) messenger RNA expression; thus, Ang II (show AGT Antibodies) and/or RLN2 (show RLN1 Antibodies) appear to be involved in regulation of apoptosis in prostate epithelium.
increasing the serum levels of AngII increased the risk of acute myocardial infarction (AMI (show CFD Antibodies)); the risk of AMI (show CFD Antibodies) increased when the serum levels of AngII and KLK1 (show KLK1 Antibodies) simultaneously increased; individuals with the combined genotypes of ACE (show ACE Antibodies) DD and KLK1 (show KLK1 Antibodies) GG showed increased risk of AMI (show CFD Antibodies) compared with those with the combined genotypes of ACE (show ACE Antibodies) II and KLK1 (show KLK1 Antibodies) AA
genetic association study and meta-analysis revealed a significant association between M235T polymorphism of angiotensinogen (show AGT Antibodies) and myocardial infarction risk
The aim of this work is to assess the influence of the rs1799752 polymorphism of the angiotensin-converting enzyme (ACE (show ACE Antibodies)) gene and the rs699 polymorphism of the angiotensinogen (AGT (show AGT Antibodies)) gene on the in-stent restenosis in Polish patients with stable coronary artery disease.
in cultured H9C2 cells and that CyPA (show PPIA Antibodies)/CD147 signaling pathway inhibition protects against Ang II (show AGT Antibodies)-induced cardiomyocyte hypertrophy.
the beneficial actions of insulin (show INS Antibodies) in diabetic nephropathy appear to be mediated, in part, by suppressing renal Nrf2 (show NFE2L2 Antibodies) and Agt (show AGXT Antibodies) gene transcription and preventing Nrf2 (show NFE2L2 Antibodies) stimulation of Agt (show AGXT Antibodies) expression via hnRNP F (show HNRNPF Antibodies)/K.
Angiotensinogen (show AGT Antibodies)-mediated downregulation of aquaporin 1 (show AQP1 Antibodies) and Nrf2 (show NFE2L2 Antibodies) signalling may play an important role in intrarenal renin (show REN Antibodies)-angiotensin system-induced hypertension and kidney injury.
This study suggests that deletion of AT2R decreases the expression of the beneficial ACE2/Ang-(1-7)/MasR.
an inverse correlation was found between Ang-(1 (show ANGPT1 Antibodies)-7) level and tau hyperphosphorylation, a pathological hallmark of Alzheimer's disease, in cerebral cortex and hippocampus of SAMP8 mice.
The inhibition of pathological autophagy in the heart in response to chronic Ang II (show AGT Antibodies) by Interleukin-10 (show IL10 Antibodies), and its implications, has been described.
These results suggest that increased formation of AT1R (show AGTRAP Antibodies)-P2Y6R (show P2RY6 Antibodies) heterodimers with age may increase the likelihood of hypertension induced by Ang II (show AGT Antibodies).
These data suggest dysregulation of renin (show REN Antibodies)-angiotensin system in acute pancreatitis as evidenced by altered Ang II/Ang-(1 (show ANGPT1 Antibodies)-7) levels induced by the imbalance of ACE (show ACE Antibodies)/ACE2 (show ACE2 Antibodies) activity.
Results indicate that Ang III (show AGT Antibodies) produces nociceptive behavior similar to Ang II (show AGT Antibodies), and suggest that the phosphorylation of p38 MAPK (show MAPK14 Antibodies) mediated through AT1 (show SLC33A1 Antibodies) receptors on spinal astrocytes and neurons contributes to Ang II (show AGT Antibodies)- and III-induced nociceptive behavior
SIRT1 (show SIRT1 Antibodies) and the axis AII (show ARG2 Antibodies)/AT1 (show SLC33A1 Antibodies)/NADPH-oxidase (show NOX1 Antibodies) regulate each other
Angiotensin (1-7) and Bradykinin may have roles in diabetic nephropathy induced by increased ACE (show ACE Antibodies) gene dosage
The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.
alpha-1 antiproteinase, antitrypsin
, angiotensin I
, angiotensin II
, serine (or cysteine) proteinase inhibitor
, serpin A8
, angiotensinogen (PAT)
, angiotensin ll